Your browser doesn't support javascript.
loading
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.
Aminu, Muhammad; Daver, Naval; Godoy, Myrna C B; Shroff, Girish; Wu, Carol; Torre-Sada, Luis F; Goizueta, Alberto; Shannon, Vickie R; Faiz, Saadia A; Altan, Mehmet; Garcia-Manero, Guillermo; Kantarjian, Hagop; Ravandi-Kashani, Farhad; Kadia, Tapan; Konopleva, Marina; DiNardo, Courtney; Pierce, Sherry; Naing, Aung; Kim, Sang T; Kontoyiannis, Dimitrios P; Khawaja, Fareed; Chung, Caroline; Wu, Jia; Sheshadri, Ajay.
Afiliación
  • Aminu M; Departments of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Daver N; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Godoy MCB; Departments of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Shroff G; Departments of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wu C; Departments of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Torre-Sada LF; Departments of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Goizueta A; Departments of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Shannon VR; Departments of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Faiz SA; Departments of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Altan M; Departments of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Garcia-Manero G; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kantarjian H; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ravandi-Kashani F; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kadia T; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Konopleva M; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • DiNardo C; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Pierce S; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Naing A; Departments of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kim ST; Departments of Rheumatology and Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kontoyiannis DP; Departments of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Khawaja F; Departments of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Chung C; Departments of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Wu J; Departments of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Sheshadri A; Departments of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Immunol ; 14: 1249511, 2023.
Article en En | MEDLINE | ID: mdl-37841255
Background: Immune checkpoint inhibitors (ICI) may cause pneumonitis, resulting in potentially fatal lung inflammation. However, distinguishing pneumonitis from pneumonia is time-consuming and challenging. To fill this gap, we build an image-based tool, and further evaluate it clinically alongside relevant blood biomarkers. Materials and methods: We studied CT images from 97 patients with pneumonia and 29 patients with pneumonitis from acute myeloid leukemia treated with ICIs. We developed a CT-derived signature using a habitat imaging algorithm, whereby infected lungs are segregated into clusters ("habitats"). We validated the model and compared it with a clinical-blood model to determine whether imaging can add diagnostic value. Results: Habitat imaging revealed intrinsic lung inflammation patterns by identifying 5 distinct subregions, correlating to lung parenchyma, consolidation, heterogenous ground-glass opacity (GGO), and GGO-consolidation transition. Consequently, our proposed habitat model (accuracy of 79%, sensitivity of 48%, and specificity of 88%) outperformed the clinical-blood model (accuracy of 68%, sensitivity of 14%, and specificity of 85%) for classifying pneumonia versus pneumonitis. Integrating imaging and blood achieved the optimal performance (accuracy of 81%, sensitivity of 52% and specificity of 90%). Using this imaging-blood composite model, the post-test probability for detecting pneumonitis increased from 23% to 61%, significantly (p = 1.5E - 9) higher than the clinical and blood model (post-test probability of 22%). Conclusion: Habitat imaging represents a step forward in the image-based detection of pneumonia and pneumonitis, which can complement known blood biomarkers. Further work is needed to validate and fine tune this imaging-blood composite model and further improve its sensitivity to detect pneumonitis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza